Wintac is planning to raise fund up to Rs 135 crore through External Commercial Borrowings (ECB) for repayment of existing bank borrowings and to meeting working capital and CAPEX requirements. The Board of Directors of the Company at its meeting to be held on April 11, 2019 to consider the same.
Wintac is a professionally managed and fully integrated pharmaceutical company that is committed in developing, manufacturing and marketing of high quality pharmaceutical formulations using innovative technologies and meeting the cGMP standards which are continuously updated to international requirements.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.50 |
| Dr. Reddys Lab | 1221.45 |
| Cipla | 1230.00 |
| Zydus Lifesciences | 930.90 |
| Lupin | 2323.05 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: